| Members |
targetComponentId |
| Potential infectious contact |
Exposure to organism (event) |
| Potexvirus group |
Genus Potexvirus (organism) |
| Potts fraktur |
Bimalleolar fracture of ankle |
| Pouched mammal |
Infraclass Metatheria (organism) |
| Pouchografi |
Fluoroscopy of ileal pouch with contrast (procedure) |
| Povidone 5% conventional release eye drops |
Povidone 50 mg/mL eye solution |
| povidon 5 % øjendråber til engangsbrug |
Povidone 50 mg/mL eye solution |
| povidoniod 10 % |
Product containing povidone iodine (medicinal product) |
| povidoniod 10 % præparat til pensling |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| povidoniod 10 % svamp til topikal anvendelse |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| povidoniod 10 % vaginalgel |
Iodine (as povidone iodine) 100 mg/g vaginal gel |
| povidoniod 20 % svamp til topikal anvendelse |
Povidone iodine only product in cutaneous dose form |
| povidoniod 200 mg vagitorium |
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
| povidoniod 5 % svamp til topikal anvendelse |
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Powder for conventional release intravesical or parenteral or urethral solution |
Powder for conventional release intravesical solution and solution for injection (dose form) |
| endotracheopulmonal instillationsvæske, pulver til opløsning |
Powder for solution for endotracheopulmonary instillation |
| Powder for conventional release suspension for endotracheal instillation |
Powder for conventional release suspension for endotracheopulmonary instillation (dose form) |
| pulver til suspension |
A solid dose form consisting of one or more particulate solids of varying degrees of fineness. |
| Powered wheelchair |
Motorized wheelchair device (physical object) |
| Poxvirus group |
Family Poxviridae (organism) |
| pramipexoldihydrochlorid tablet 125 µg |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
| pramipexoldihydrochlorid tablet 1 mg |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
| pramipexoldihydrochlorid tablet 250 µg |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
| Pramlintide 1mg/mL injection solution prefilled pen |
Pramlintide only product |
| Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
| Præeklampsi, ikke nærmere specificeret |
Pre-eclampsia (disorder) |
| Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
| Præeklampsi eller eklampsi med forud eksisterende hypertension, med postnatal komplikation |
Pre-eclampsia or eclampsia with pre-existing hypertension |
| Pre-excitation atrioventricular conduction |
Accelerated atrioventricular conduction |
| forudgående behandling ændret præoperativt af anæstesiolog |
Pre-existing therapy altered by anesthetist preoperatively (situation) |
| Pre-primary teacher NOS |
Pre-primary education teacher |
| Pre-primary teacher NOS |
Pre-primary education teacher |
| Di-Te-vaccination i førskolealderen |
Preschool administration of diphtheria and tetanus vaccine |
| Precautionary nursing procedure |
Nursing procedure |
| Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
| Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
| Styrtfødsel med prænatalt problem |
Precipitate labor |
| Prediabetes |
Characterized by blood glucose levels that are higher than normal but not yet high enough to be classed as diabetes. Indicates a relatively high risk for the future development of diabetes. |
| prednisolon 0,001 % øjendråber |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
| prednisolon 0,003 % øjendråber |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.01% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| prednisolon 0,01 % øjendråber |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| prednisolon 0,01 % øjendråber uden konserveringsmiddel |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| Prednisolone 0.03% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| prednisolon 0,03 % øjendråber |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| prednisolon 0,03 % øjendråber uden konserveringsmiddel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.1% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| prednisolon 0,1 % øjendråber |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| prednisolon 0,1 % øjendråber uden konserveringsmiddel |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| Prednisolone 0.3% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| prednisolon 0,3 % øjendråber |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
| prednisolon 0,3 % øjendråber uden konserveringsmiddel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
| Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
| prednisolon 20 mg/100 ml retentionsklysma med langt rektalrør |
Prednisolone only product in rectal dose form |
| prednisolon 20 mg/100 ml retentionsklysma med standardrektalrør |
Prednisolone only product in rectal dose form |
| prednisolonacetat 5 mg + sulfacetamidnatrium 100 mg salve |
Prednisolone and sulfacetamide only product in ocular dose form |
| prednisolonacetat 25 mg/ml |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
| prednisolonacetat 25 mg/ml suspension |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
| allergi over for prednisolondråber |
Allergy to prednisolone |
| predinsolonhexanoat 1,3 mg + cinchocain suppositorium a 1 mg |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
| Prednisolone sodium phosphate 0.5% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
| prednisolonnatriumphosphat 0,5 % øjendråber til engangsbrug |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
| prednisolonnatriumphosphat 1 % opløsning |
Product containing precisely prednisolone sodium phosphate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| prednisolonnatriumphosphat 1/8 % opløsning |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Præfabrikeret krone i rustfrit stål, blivende tand |
Restoration of permanent tooth with preformed stainless steel crown (procedure) |
| Præfabrikeret krone i rustfrit stål, primær tand |
Restoration of deciduous tooth with preformed stainless steel crown (procedure) |
| Temperaturpræference for drikkevarer |
Preference for temperature of drink (observable entity) |
| Temperaturpræference for madvarer |
Preference for temperature of food (observable entity) |
| Preglaucoma |
At least 1 of these in 1 eye: optic nerve or nerve fibre layer suggestive of glaucoma; abnormal visual field consistent with glaucoma; an elevated IOP > 22 mm Hg. |
| graviditet og afhængighed af psykoaktive stoffer og lægemidler |
Pregnancy and substance dependence (disorder) |
| Pregnancy benefit NOS |
Pregnancy benefits |
| Pregnancy benefit NOS |
Pregnancy benefits |
| Graviditetskomplikationer, ikke nærmere specificeret |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy complications NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| forlænget graviditet - 41 uger |
Gestation period extended beyond 42 weeks or 294 days from the first day of the last menstrual period. |
| forlænget graviditet - 42 uger |
Gestation period extended beyond 42 weeks or 294 days from the first day of the last menstrual period. |
| Graviditet med abort som udfald, ikke nærmere specificeret |
Pregnancy with abortive outcome |
| Pregnancy with abortive outcome NOS |
Pregnancy with abortive outcome |
| Graviditet med sygdom, ikke nærmere specificeret |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy with medical condition NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy with other medical condition |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Graviditet med anden sygdom |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy, childbirth and puerperal disorders |
Disorder of pregnancy |
| gravid kvinde |
Patient currently pregnant |
| Præmatur abnorm placenta |
Premature aging of placenta |
| Premature ejaculation |
Premature ejaculation |
| Præterm hindebristning med prænatalt problem |
Premature rupture of membranes |
| Præmaturitet hos foster |
Prematurity of infant (disorder) |
| Premenstrual tension |
Premenstrual tension syndrome |
| vitamin til prænatal anvendelse |
Vitamin |
| Preoperative nursing procedure |
Preoperative care |
| Præoperative procedurer |
Preoperative procedure |
| Preputial skin flap |
Skin flap (substance) |
| Preretinal fibrosis |
Epiretinal membrane |
| Prescription telephone order |
Prescription ordered by telephone |
| Presence of complement |
Complement assay |
| Presence of complement component 3 |
Complement assay |
| Presence of complement component 4 |
Complement assay |
| Presence of drugs of abuse |
Drug, confirmation assay |
| Presence of heavy metal |
Heavy metal screen |
FHIR